EmbryoClinic
EmbryoClinic is a private fertility clinic in Thessaloniki, Greece, founded in 2013 by Dr. Elias Tsakos, offering IVF, ICSI, IUI, donor programmes, surrogacy, PGT, PRP, and robotic fertility surgery to domestic and international patients from 45+ countries.
- Company typePrivate
- Founded2013
- HeadquartersKalamariá, Greece
- Headcount11–50
- GTM typeB2C
- OfferingServices
What EmbryoClinic does
EmbryoClinic is a privately held assisted reproduction clinic headquartered in Thessaloniki, Greece, founded in 2013 by Dr. Elias Tsakos. The clinic operates a single integrated IVF unit delivering the full spectrum of fertility services: IVF/ICSI, IUI, fertility preservation (oocyte, embryo, and sperm cryopreservation), oocyte/sperm/embryo donation, gestational surrogacy, preimplantation genetic testing (PGT-A via NGS and PGT-M), endometrial and ovarian PRP infusion, and minimally invasive gynaecological surgery including Da Vinci robotic procedures. The embryology laboratory incorporates 24-hour time-lapse embryo monitoring combined with AI-assisted embryo selection, and the practice runs a proprietary in-house electronic patient record system (MedAZ) that won the Hellenic Business Innovation Award in 2022. The clinical team is led by Dr. Tsakos as Medical Director (FRCOG, 30+ years experience, 10,000+ cases across obstetrics, gynaecological surgery, and reproductive medicine) and Dr. Kanelina Bimpa as CEO, supported by an embryology lab director, senior clinical embryologists (including ESHRE-certified staff), obstetrician-gynaecologists, fertility midwives, and dedicated patient coordinators.
The clinic's go-to-market is direct-to-consumer with a deliberate medical tourism focus, providing free initial Skype consultations, dedicated International and Balkan patient coordinator departments, and structured fresh and frozen oocyte programmes tailored to overseas patients requiring limited visits. Patients are sourced from 45+ countries, with Greece positioned as materially cheaper than UK and US alternatives. The revenue model is fee-for-service professional services billed per treatment cycle on a pay-as-you-go basis across multiple pricing tiers. Marketing is led by founder-driven thought leadership (100+ conference presentations, 33 peer-reviewed publications, 147 citations), content marketing across five social channels, and partnerships with fertility information platforms. Recent strategic activity includes the 1st Pelvic Floor Surgery Masterclass (May 2025) and the 2nd HERGS Scientific Meeting (April 2026), positioning the clinic and its founder at the centre of robotic gynaecological surgery education in Greece and Europe.
EmbryoClinic firmographics
Firmographics- Name
- EmbryoClinic
- Legal name
- EmbryoClinic
- Website
- https://embryoclinic.eu
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EmbryoClinic is a private fertility clinic in Thessaloniki, Greece, founded in 2013 by Dr. Elias Tsakos, offering IVF, ICSI, IUI, donor programmes, surrogacy, PGT, PRP, and robotic fertility surgery to domestic and international patients from 45+ countries.
- Ownership category
- akta.pro rank
EmbryoClinic industry classification
Industry- Product category
- Reproductive Medicine / Fertility Services
- NAICS
- Family Planning Centers (621410)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Fertility/IVF & Reproductive Tourism Agencies (THAKAIAF)
Keywords
Where EmbryoClinic is headquartered
LocationHeadquarters
- HQ city
- Kalamariá
- HQ country
- Greece
- HQ region
- Europe
Offices1 record
Markets served
EmbryoClinic business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Assisted Reproduction Medical Services: EmbryoClinic generates revenue through providing fee-for-service medical treatments including IVF/ICSI, fertility surgery, oocyte and sperm donation programmes, gestational surrogacy, fertility assessments, diagnostic testing, and related procedures. Services are delivered at the clinic in Thessaloniki, Greece.
- Oocyte Donation Programme: Both open (non-anonymous) and anonymous donor programmes, with fresh and frozen oocyte options. The clinic matches donors with recipients based on physical characteristics and provides the full scope of donor preparation, oocyte retrieval, and fertilization services.
- Medical Tourism Services: International patient services including coordination of multiple visits, Skype consultations, treatment planning, and on-site care for patients travelling from abroad (45+ countries).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Fresh Oocyte Programme — Two clinic visits, 2-3 days stay each, 6-8 mature oocytes |
| Other | Pay-as-you-go | Frozen Oocyte Programme — Single clinic visit, 7 days stay, 8 mature oocytes |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
EmbryoClinic product offering
Product offeringCore offering
EmbryoClinic operates an assisted reproduction clinic in Thessaloniki, Greece, delivering a full spectrum of fertility services under one roof: IVF/ICSI, intra-uterine insemination (IUI), fertility preservation (oocyte, embryo and sperm cryopreservation), oocyte and sperm/embryo donation programmes, gestational surrogacy, preimplantation genetic testing (PGT-A and PGT-M), endometrial and ovarian PRP infusion, and minimally invasive fertility surgery including Da Vinci robotic procedures. Services are delivered by a multidisciplinary team led by Medical Director Dr. Elias Tsakos and supported by an in-house embryology lab, advanced AI-assisted embryo selection, and dedicated international patient coordinators serving families from more than 45 countries.
Product overview
EmbryoClinic is a comprehensive assisted reproduction and fertility clinic based in Thessaloniki, Greece, founded in 2013 by Dr. Elias Tsakos. The clinic operates as a single, integrated fertility unit offering a full spectrum of services organized around its core IVF/ICSI programme. The portfolio includes fertility preservation (oocyte, embryo, and sperm cryopreservation), donor programmes (oocyte donation, sperm/embryo donation), gestational surrogacy, preimplantation genetic testing (PGT-A and PGT-M), and endometrial/ovarian PRP therapy. Surgical fertility services are delivered through Female Fertility Surgery encompassing laparoscopic, hysteroscopic, and Da Vinci robotic surgery. The clinic also provides advanced diagnostic services including 3D/4D ultrasound, time-lapse embryo monitoring with AI-powered embryo selection, comprehensive male and female fertility assessments, and holistic supportive care. All services are supported by a state-of-the-art embryology laboratory, an experienced multidisciplinary team of 25+ years' standing, and international patient coordination serving families from over 45 countries worldwide.
Differentiator
Problem solved
Functional benefit
Products and services
- IVF/ICSI (In Vitro Fertilization / Intracytoplasmic Sperm Injection)
Quantifiable outcome
- Up to 60% higher implantation rate with endometrial PRP
- +7 more outcomes
Companies that use EmbryoClinic
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
EmbryoClinic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
EmbryoClinic partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered flagship, core and minor.
- Hellenic Robotic Gynaecological Society (HERGS)flagshipEmbryoClinic, under the leadership of Dr. Elias Tsakos (President of HERGS), co-organises scientific events including the 2nd HERGS Scientific Meeting (April 4, 2026) and the 1st Masterclass on Pelvic Floor Surgery (May 24, 2025). These events position the clinic at the forefront of robotic gynaecological surgery innovation in Greece and Europe.
- Royal College of Obstetricians & Gynaecologists (RCOG)coreDr. Tsakos serves as Chair of the Hellenic International Representative Committee of RCOG. HERGS events operate under the auspices of RCOG's Hellenic Delegation. The collaboration supports medical education and certification standards in obstetrics and gynaecology.
- GynSurgery TeamcoreGynSurgery is a team of well-trained and highly experienced gynaecological surgeons founded and led by Dr. Elias Tsakos, specialising in fertility surgery and minimally invasive solutions including robotic surgery. This is an affiliated surgical practice that operates alongside EmbryoClinic.
- St. Luke's Hospital (Κλινική Άγιος Λουκάς)coreEmbryoClinic's medical team is affiliated with St. Luke's Hospital in Thessaloniki where Dr. Tsakos serves as Director of Robotic Gynaecological Surgery. Many team members work across both facilities, and hospital-based surgeries and masterclasses are conducted there.
- The Ribbon BoxminorEmbryoClinic partners with The Ribbon Box, a fertility information platform, for article publication and referral of international patients considering fertility treatment abroad.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
EmbryoClinic competitors and assessment
Company assessmentRegional players
- CREATE Fertility: UK-based fertility clinic chain with a strong focus on mild/natural-cycle IVF and high international patient intake. Comparable as a UK market competitor pulling patients who would otherwise consider Greek medical tourism for cost or donor-availability reasons.
- Beacon CARE Fertility (Ireland): Irish fertility clinic providing IVF, ICSI, donor, and reproductive surgery, serving patients who might otherwise travel to the UK or Southern Europe. Comparable as a regional alternative in the broader British Isles fertility market that competes for the same medical-tourism patient segments.
Direct peers
- Boston IVF: Established US fertility clinic network providing IVF, PGT, donor egg, and third-party reproduction services. Comparable on full-service ART, donor programs, and reproductive surgery scope.
- Gennima Fertility Centre: Athens-based Greek fertility clinic offering IVF, ICSI, PGT, egg/sperm donation, and surrogacy coordination. Closest direct competitor within Greece on full-service fertility offerings and English-language international patient handling.
- Instituto Bernabeu (Spain): Mediterranean fertility clinic with a strong international patient base, advanced PGT/NGS genetics, and AI embryo selection. Comparable as a Southern-European medical-tourism alternative with similar regulatory and pricing positioning.
- Institut Marquès (Spain): Barcelona-based fertility clinic known internationally for egg donation and comprehensive IVF, with a strong international patient program including English-language coordination. Comparable on Mediterranean medical-tourism fertility positioning and donor programme depth.
- CCRM (Colorado Center for Reproductive Medicine): Multi-site US fertility network with deep PGT, AI embryo scoring, and reproductive surgery capability. Comparable on technology stack (time-lapse, AI embryo selection, large donor programs) and premium patient positioning.
- Newlife IVF Centre (Thessaloniki): Greek fertility clinic based in Thessaloniki providing IVF, ICSI, PGD, and donor programmes to a similar domestic and international patient mix. Directly comparable on geography, service scope, and medical-tourism positioning in Northern Greece.
Broad incumbents
- TFP (The Fertility Partnership): Pan-European fertility clinic group (UK and Continental Europe) with IVF, ICSI, donor, and surrogacy pathways. Comparable as a UK-facing fertility provider managing cross-border patient flows into and out of the UK market.
- IVI-RMA (IVIRMA Global): One of the world's largest fertility networks with clinics across Spain, Portugal, Latin America, and beyond, offering the full ART stack. Comparable on advanced reproductive technology and international patient pathways, but at significantly greater scale and brand breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
EmbryoClinic social profiles
Digital presenceEmbryoClinic financial estimates
Financial estimateRevenue estimate
Valuation estimate
EmbryoClinic leadership team
Management profileNumber of profiles
Profiles11 records
EmbryoClinic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EmbryoClinic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EmbryoClinic
What does EmbryoClinic do?
EmbryoClinic operates an assisted reproduction clinic in Thessaloniki, Greece, delivering a full spectrum of fertility services under one roof: IVF/ICSI, intra-uterine insemination (IUI), fertility preservation (oocyte, embryo and sperm cryopreservation), oocyte and sperm/embryo donation programmes, gestational surrogacy, preimplantation genetic testing (PGT-A and PGT-M), endometrial and ovarian PRP infusion, and minimally invasive fertility surgery including Da Vinci robotic procedures. Services are delivered by a multidisciplinary team led by Medical Director Dr. Elias Tsakos and supported by an in-house embryology lab, advanced AI-assisted embryo selection, and dedicated international patient coordinators serving families from more than 45 countries.
Is EmbryoClinic a public or private company?
EmbryoClinic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was EmbryoClinic founded?
EmbryoClinic was founded in 2013. It employs 11 to 50 people.
Where is EmbryoClinic based?
EmbryoClinic is headquartered in Kalamariá, Greece, in the Europe region.
How does EmbryoClinic make money?
Three revenue lines are on record. Assisted Reproduction Medical Services are the primary driver. The others are oocyte Donation Programme and medical Tourism Services.
Who are EmbryoClinic's main competitors?
Regional players on record are CREATE Fertility and Beacon CARE Fertility (Ireland). Direct peers are Boston IVF, Gennima Fertility Centre, Instituto Bernabeu (Spain), Institut Marquès (Spain), CCRM (Colorado Center for Reproductive Medicine) and Newlife IVF Centre (Thessaloniki). Broad incumbents are TFP (The Fertility Partnership) and IVI-RMA (IVIRMA Global).
Does EmbryoClinic have an API?
No public API is recorded for EmbryoClinic.
What industry is EmbryoClinic in?
EmbryoClinic's product category is Reproductive Medicine / Fertility Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 621410 and its SIC code is 8011.